Simaya AI

Simaya AI
Simaya AI provides biologically-driven patient drug predictions for pharma and biotech, enhancing clinical trial success with individual response, toxicity, and dosage insights.
About
Technology stack
detected 2026-07-03No comments yet. Be the first to share your take.
What does Simaya AI do?
Simaya AI provides patient drug prediction by modeling the biology behind drug responses to estimate who a drug is most likely to help before clinical trials begin. Their platform serves pharma and biotech R&D teams by offering per-patient predictions for treatment response, toxicity, and optimal dosage, enabling more precise patient selection for clinical trials. This approach reasons from biology, not just correlation, to provide mechanistic, inspectable reasons for each prediction.
Where is Simaya AI headquartered?
Simaya AI is headquartered in גת (קיבוץ), Israel.
When was Simaya AI founded?
Simaya AI was founded in 2026.
What industry does Simaya AI operate in?
Simaya AI operates in Biotech, Drug Discovery, Clinical Trials, AI-Driven Drug Discovery, Precision Medicine, Genomics.